Medical Doctor: Universidad Complutense de Madrid, España (1996 – 2003)
Specialist in Allergy: Hospital Ramón y Cajal, Madrid, España (2004-2008)
PhD “Cum Laude” (2011): Research : Harvard University, Boston, USA. Diploma: Universidad de Alcalá de Henares, Madrid, España
1 Legere HJ, 3rd, Palis RI, Rodriguez Bouza T, Uluer AZ, Castells MC: A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity. J Cyst Fibros 2009;8:418-424.
2 Brennan PJ, Rodriguez Bouza T, Hsu FI, Sloane DE, Castells MC: Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. J Allergy Clin Immunol 2009;124:1259-1266.
3 Al-Ahmad M, Rodriguez Bouza T, Arifhodzic N: PCN allergy evaluation: experience from a drug allergy clinic in an Arabian Gulf Country, Kuwait. Asia Pac Allergy 2014;4:106-112.
4 Al-Ahmad M, Rodriguez Bouza T: Pattern of inpatient referrals to a drug allergy unit in Kuwait. Eur Ann Allergy Clin Immunol 2017;49:276-280.
5 Al-Ahmad M, Bouza TR: Successful desensitization to radiocontrast media in two high-risk cardiac patients. Ann Saudi Med 2017;37:333-335.
6 Al-Ahmad M, Rodriguez-Bouza T: Drug allergy evaluation for betalactam hypersensitivity: Cross-reactivity with cephalosporines, carbapenems and negative predictive value. Asian Pac J Allergy Immunol 2018;36:27-31.
7 Al Ahmad M, Arifhodzic N, Nurkic J, Jusufovic E, Hanoun AL, Rodriguez T: Role of nasal challenge and local eosinophilia in indirect exposure to cat in allergic rhinitis patients. Eur Ann Allergy Clin Immunol 2018;50:125-131.
8 Al-Ahmad M, Rodriguez-Bouza T, Fakim N, Pineda F: Extensive Cross-reactivity Between Salsola kali and Salsola imbricata. J Investig Allergol Clin Immunol 2018;28:29-36.
9 Al-Ahmad M, Rodriguez-Bouza T, Nurkic M: Establishing a Safe Administration of ASA in Cardiovascular Patients with Nonsteroidal Anti-Inflammatory Drug Hypersensitivity with Skin and/or Respiratory Involvement. Int Arch Allergy Immunol 2018;175:237-245.
10 Al-Ahmad M, Arifhodzic N, Nurkic J, Maher A, Rodriguez-Bouza T, Al-Ahmed N, Sadek A, Jusufovic E: “Real-life” Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma. Med Princ Pract 2018;27:260-266.
11 Al-Ahmad M, Jusufovic E, Arifhodzic N, Rodriguez T, Nurkic J: Association of molds and metrological parameters to frequency of severe asthma exacerbation. Allergy Asthma Clin Immunol 2019;15:29.
12 Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. The Journal of Allergy and Clinical Immunology: In Practice 2020:S117-S122
Kuwait patient data registry: First large-scale patients data registry on Drug Allergy in the Middle East.
He has contributed in 2020 as an author to the world’s leading drug allergy guide, developed by the American Academy of Allergy, Asthma, and Clinical Immunology (AAAAI).
Chapter: Desensitization to antibiotics.
Book: Anaphylaxis and Hypersensitivity Reactions: From Molecular Markers to Rapid Desensitizations ; Editor: Springer. 2009
Journal of Allergy and Clinical Immunology: In practice
World Allergy Journal.
Asian Pacific journal of Allergy and Immunology
Official guide for the Management of COVID-19 in Adults, Kuwait Ministry of Health.
Hospital Ramon y Cajal. Madrid, Spain. 2004 – 2008
Brigham and Women’s Hospital, Harvard University affiliated. Boston, MA, EEUU. 2008 – 2011
Clinica Capio, Madrid, Spain. 2011 – 2012
Al-Rashed Allergy Center, Kuwait. 2012 – 2018
Topdoctors, Spain. 2018 –
International Cooperation, expert degree on international cooperation from Nursery School of Complutense University, Madrid , Spain. Experience on volunteer and NGOs.
Member of the International Cooperation Committee of theSpanish Society for Allergy and Clinical Immunology
Sports: Ironman Triathlon, Ultramarathon.
Blockchain: CEO www.dynamicblockchain.net , Middle East advisor for Medichain.